-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UzR+UK+dBjXloSCOcSevJLFrdEuSU3lPt0DXGjhZ2l95J7EPv7sHVEzXdqsfU0NR nk9MvOm3O1a90bfY5stMCA== 0001250853-10-000003.txt : 20100127 0001250853-10-000003.hdr.sgml : 20100127 20100127130856 ACCESSION NUMBER: 0001250853-10-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100127 DATE AS OF CHANGE: 20100127 EFFECTIVENESS DATE: 20100127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC. CENTRAL INDEX KEY: 0001335105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202903526 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-94096 FILM NUMBER: 10549911 BUSINESS ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 BUSINESS PHONE: 310 203 2902 MAIL ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 7 INC DATE OF NAME CHANGE: 20050803 D 1 primary_doc.xml X0603 D LIVE 0001335105 LIXTE BIOTECHNOLOGY HOLDINGS, INC. 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 631-942-7959 DELAWARE SRKP 7 INC Corporation true 2005 John S. Kovach 248 Route 25A No. 2 East Setauket NY 11733 Executive Officer Director Stephen K. Carter 248 Route 25A No. 2 East Setauket NY 11733 Director Philip F. Palmedo 248 Route 25A No. 2 East Setauket NY 11733 Director Mel Sorenson 248 Route 25A No. 2 East Setauket NY 11733 Director Biotechnology No Revenues 06 false 2010-01-20 false true Units - each unit consisted of 1 share of common stock, 1 warrant to purchase 1 share of common stock at $.50 per share, 1 warrant to purchase 1 share of common stock at $.75 per share. false 0 1787500 1787500 0 false 14 0 0 0 false LIXTE BIOTECHNOLOGY HOLDINGS, INC. /s/ John S. Kovach John S. Kovach Chief Executive Officer 2010-01-26 -----END PRIVACY-ENHANCED MESSAGE-----